급성 두통환자의 거미막밑출혈 예측을 위한 호중구/림프구 비율 및임상 예측 지표방법의 유용성 = Efficacy of neutrophil-lymphocyte ratio and clinical predicting indexes on differentiating subarachnoid hemorrhage from acute headache patients at emergency department

다국어 초록 (Multilingual Abstract)

Objective: This study evaluated the clinical usefulness of the neutrophil-lymphocyte ratio (NLR), Ottawa subarachnoid hemorrhage (SAH) rule and EMERALD (Emergency Medicine, Registry Analysis, Learning and Diagnosis) SAH rule for predicting SAH in patients with acute headache.
Methods: This clinical retrospective study was conducted at an urban emergency department between January 2008 and December 2017. Alert, neurologically intact adult patients with acute headache were included. All data were drawn from electrical medical charts. The Ottawa SAH rule (positive if any of age ≥40, neck pain, loss of consciousness, onset during exertion, thunderclap headache, and neck stiffness), EMERALD SAH rule (positive if any of systolic blood pressure >150 mmHg, diastolic blood pressure >90 mmHg, serum glucose >115 mg/dL, or serum potassium <3.9 mEq/L) and NLR were assessed. The sensitivity and specificity of these tools for detecting or ruling out SAH was calculated.
Results: Among the 1,230 patients enrolled in this study, 299 (24.3%) were diagnosed with SAH. To predict SAH, the Ottawa SAH rule offered 100% sensitivity but 31.6% specificity. Applying the EMERALD SAH rule to patients positive for the Ottawa SAH rule led to 92.6% sensitivity and 48.0% specificity. As the NLR alone showed less efficacy with the area under curve of 0.696 by receiver operating analysis, NLR (>2.1) was added to the last step to have achieve 99.0% sensitivity and 56.7% specificity.
Conclusion: The stepwise application of the Ottawa, EMERALD SAH rule, and NLR increased the specificity compared to each application. On the other hand, further studies will be needed to increase the sensitivity.

참고문헌 (Reference)

1 Perry JJ, "Validation of the Ottawa Subarachnoid Hemorrhage Rule in patients with acute headache" 189 : E1379-E1385, 2017

2 Eryigit U, "The diagnostic value of the neutrophil-lymphocyte ratio in distinguishing between subarachnoid hemorrhage and migraine" 35 : 1276-1280, 2017

3 Fujiki Y, "Serum glucose/potassium ratio as a clinical risk factor for aneurysmal subarachnoid hemorrhage" 2017

4 Gee C, "Sensitivity of newergeneration computed tomography scanners for subarachnoid hemorrhage: a Bayesian analysis" 43 : 13-18, 2012

5 Dubosh NM, "Sensitivity of early brain computed tomography to exclude aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis" 47 : 750-755, 2016

6 Friedrich V, "Reduction of neutrophil activity decreases early microvascular injury after subarachnoid haemorrhage" 8 : 103-, 2011

7 Mark DG, "Nontraumatic subarachnoid hemorrhage in the setting of negative cranial computed tomography results: external validation of a clinical and imaging prediction rule" 62 : 1-10, 2013

8 Kimura A, "New clinical decision rule to exclude subarachnoid haemorrhage for acute headache: a prospective multicentre observational study" 6 : e010999-, 2016

9 Vermeulen MJ, "Missed diagnosis of subarachnoid hemorrhage in the emergency department" 38 : 1216-1221, 2007

10 Kowalski RG, "Initial misdiagnosis and outcome after subarachnoid hemorrhage" 291 : 866-869, 2004

11 Naredi S, "Increased sympathetic nervous activity in patients with nontraumatic subarachnoid hemorrhage" 31 : 901-906, 2000

12 de Rooij NK, "Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends" 78 : 1365-1372, 2007

13 Kruyt ND, "Hyperglycemia and clinical outcome in aneurysmal subarachnoid hemorrhage: a meta-analysis" 40 : e424-e430, 2009

14 Schofield ML, "How well do we investigate patients with suspected subarachnoid haemorrhage? The continuing need for cerebrospinal fluid investigations" 80 : 27-30, 2004

15 Perry JJ, "High risk clinical characteristics for subarachnoid haemorrhage in patients with acute headache: prospective cohort study" 341 : c5204-, 2010

16 Connolly ES Jr, "Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association" 43 : 1711-1737, 2012

17 Reid JL, "Epinephrine-induced hypokalemia: the role of beta adrenoceptors" 57 : 23F-27F, 1986

18 Frijns CJ, "Endothelial cell activation markers and delayed cerebral ischaemia in patients with subarachnoid haemorrhage" 77 : 863-867, 2006

19 Perry JJ, "Differentiation between traumatic tap and aneurysmal subarachnoid hemorrhage: prospective cohort study" 350 : h568-, 2015

20 Tao C, "Clinical value of neutrophil to lymphocyte and platelet to lymphocyte ratio after aneurysmal subarachnoid hemorrhage" 26 : 393-401, 2017

21 Edlow JA, "Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with acute headache" 52 : 407-436, 2008

22 Perry JJ, "Clinical decision rules to rule out subarachnoid hemorrhage for acute headache" 310 : 1248-1255, 2013

23 Edlow JA, "Avoiding pitfalls in the diagnosis of subarachnoid hemorrhage" 342 : 29-36, 2000

24 Hollig A, "Association of early inflammatory parameters after subarachnoid hemorrhage with functional outcome: a prospective cohort study" 138 : 177-183, 2015

25 Chu KH, "Applying the Ottawa subarachnoid haemorrhage rule on a cohort of emergency department patients with headache" 2017

26 Suarez JI, "Aneurysmal subarachnoid hemorrhage" 354 : 387-396, 2006